|Google news stem cell headlines this week|
- "How much further will the FDA go with actual enforcement actions?
- "Will the FDA define fat stem cells as a drug (or not) in upcoming guidances?
- "How will the FDA handle non-homologous use of bone marrow cells in the commercial sector?
- "Will the FDA work to deal with the growing problem of unapproved, amniotic stem cell offerings?
- "What about networks of stem cell businesses?
- "Will other entities like state medical boards use this FDA action as a spring-board to get off the sidelines and take positive action too?"